Fig. 3From: Double-diabetes in a real-world sample of 2711 individuals: associated with insulin treatment or part of the heterogeneity of type 1 diabetes?Estimated marginal means and 95 % CIs (according to BMI status) for insulin dose (a divided by diabetes duration; b divided by gender); total number of insulin applications (c divided by diabetes duration; d divided by gender); HbA1c (e divided by diabetes duration; f divided by gender). Significant differences (p < 0.05) are marked with asterisks Back to article page